Related Experiment Video
Updated: Jun 20, 2026

Conducting Maximal and Submaximal Endurance Exercise Testing to Measure Physiological and Biological Responses to Acute Exercise in Humans
Published on: October 17, 2018
Performance-Enhancing Drugs: Where Should the Line be Drawn and by Whom?
1Associate Clinical Professor, University of California, San Diego, School of Medicine.
Abstract:
The integrity of sport is predicated on the assumption that all athletes compete on a level playing field. Unfortunately, the use and abuse of performance-enhancing drugs has become ubiquitous, creating complex challenges for the governing bodies of individual sports. This article examines the complexity of these issues within the world of professional golf, major league baseball, and Olympic competition. Integral concepts like, "What is a therapeutic exemption?" and "When does restorative function end and performance enhancement begin?" are discussed in detail.
Related Concept Videos
Drug Control Governance: Regulatory Bodies and Their Impact
Drug Regulation
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Factors Affecting Drug Distribution: Physiological Barriers
The capillary endothelial barrier allows only smaller molecules below 600 Da (Daltons) to pass through. It also restricts drugs like heparin that are bound to blood components, limiting their movement within the bloodstream.
The...
Nonlinear Pharmacokinetics: Role of Transporters
Polymorphisms occurring in drug transporters can alter...
